- Home
- ETON vs OPOF Comparison
ETON vs OPOF Comparison
Compare ETON & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- OPOF
- Stock Information
- Founded
- ETON 2017
- OPOF 1922
- Country
- ETON United States
- OPOF United States
- Employees
- ETON N/A
- OPOF N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- OPOF Major Banks
- Sector
- ETON Health Care
- OPOF Finance
- Exchange
- ETON Nasdaq
- OPOF Nasdaq
- Market Cap
- ETON 388.3M
- OPOF 207.7M
- IPO Year
- ETON 2018
- OPOF N/A
- Fundamental
- Price
- ETON $14.38
- OPOF $40.12
- Analyst Decision
- ETON Strong Buy
- OPOF
- Analyst Count
- ETON 3
- OPOF 0
- Target Price
- ETON $29.67
- OPOF N/A
- AVG Volume (30 Days)
- ETON 631.6K
- OPOF 57.3K
- Earning Date
- ETON 08-07-2025
- OPOF 07-24-2025
- Dividend Yield
- ETON N/A
- OPOF 1.38%
- EPS Growth
- ETON N/A
- OPOF 55.28
- EPS
- ETON N/A
- OPOF 1.96
- Revenue
- ETON $48,327,000.00
- OPOF $61,370,000.00
- Revenue This Year
- ETON $103.21
- OPOF N/A
- Revenue Next Year
- ETON $51.34
- OPOF N/A
- P/E Ratio
- ETON N/A
- OPOF $20.76
- Revenue Growth
- ETON 40.88
- OPOF 5.28
- 52 Week Low
- ETON $3.25
- OPOF $15.13
- 52 Week High
- ETON $21.48
- OPOF $41.33
- Technical
- Relative Strength Index (RSI)
- ETON 42.09
- OPOF 57.75
- Support Level
- ETON $13.78
- OPOF $40.27
- Resistance Level
- ETON $16.27
- OPOF $40.91
- Average True Range (ATR)
- ETON 0.80
- OPOF 0.61
- MACD
- ETON 0.15
- OPOF 0.02
- Stochastic Oscillator
- ETON 38.05
- OPOF 69.68
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.